Fotherby M D, Potter J F
University Department of Medicine for the Elderly, Glenfield Hospital, Leicester, UK.
J Hum Hypertens. 1994 Nov;8(11):857-63.
The aims of this study were to determine: (1) the proportion of elderly hypertensive subjects currently attending a hospital hypertension clinic suitable for a trial of antihypertensive drug withdrawal, (2) the proportion of suitable patients who can be successfully withdrawn from drug therapy while receiving nonpharmacological advice, and (3) the factors associated with successful withdrawal. One hundred and five consecutive hypertensive subjects, 53% female, mean age 76 years (range 65-84 years) on pharmacological antihypertensive therapy for > 1 year were studied, of whom 78 (74%) had a clinic SBP < 175 mmHg and DBP < 100 mmHg. Subjects with recent myocardial infarction or stroke or with symptoms of ischaemic heart disease were excluded. Antihypertensive drug therapy was withdrawn in this group and nonpharmacological advice to lower BP was instituted. Clinic BP and weight were subsequently recorded monthly for 12 months in all subjects and at every three months in those who had a possible follow-up period of 24 months. The 24h ambulatory BP was measured at baseline and repeated one month off therapy; 24h urine electrolytes were also assessed at baseline and at 12 months or before restarting drug therapy. Seventy-four (70%) subjects had a potential follow-up of 12 months (four were withdrawn from the study) and 64 were available for two years of follow-up. Antihypertensive treatment was restarted if SBP > or = 160 mmHg and/or DBP > or = 90 mmHg on two consecutive visits. After 12 months, 20 (25%) of those withdrawn remained normotensive, the majority restarting therapy did so in the first three months.(ABSTRACT TRUNCATED AT 250 WORDS)
(1)目前在医院高血压门诊就诊且适合进行降压药物撤药试验的老年高血压患者比例;(2)在接受非药物建议的同时能够成功撤药的合适患者比例;(3)与成功撤药相关的因素。对105例连续的高血压患者进行了研究,其中53%为女性,平均年龄76岁(范围65 - 84岁),接受药物降压治疗超过1年,其中78例(74%)诊所收缩压<175 mmHg且舒张压<100 mmHg。排除近期有心肌梗死或中风或有缺血性心脏病症状的患者。该组患者停用降压药物治疗,并给予降低血压的非药物建议。随后,所有受试者每月记录诊所血压和体重,为期12个月,对于可能有24个月随访期的患者每三个月记录一次。在基线时测量24小时动态血压,并在停药1个月后重复测量;在基线时以及12个月时或重新开始药物治疗前还评估24小时尿电解质。74例(70%)受试者有12个月的潜在随访期(4例退出研究),64例可进行两年随访。如果连续两次就诊时收缩压≥160 mmHg和/或舒张压≥90 mmHg,则重新开始降压治疗。12个月后,撤药的患者中有20例(25%)仍保持血压正常,大多数重新开始治疗的患者在前三个月内就重新用药了。(摘要截断于250字)